Genmab A/S (CPH:GMAB)

Genmab Ratios and Metrics

Market cap in millions DKK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	134,410	94,810	140,770	192,229	172,063	161,105
Market Cap Growth	48.22%	-32.65%	-26.77%	11.72%	6.80%	67.11%
Enterprise Value	113,601	78,479	114,038	169,070	153,757	143,973
Last Close Price	2182.00	1492.50	2155.00	2941.00	2630.00	2463.00
PE Ratio	13.66	12.09	32.35	35.26	58.19	33.86
Forward PE	19.46	17.44	29.87	39.46	58.46	110.38
PS Ratio	5.49	4.40	8.55	13.25	20.44	15.93
PB Ratio	3.67	2.58	4.45	7.05	7.75	8.43
P/TBV Ratio	5.79	4.35	4.47	7.08	7.84	8.58
P/FCF Ratio	15.90	12.50	20.07	53.47	87.08	26.30
P/OCF Ratio	15.43	12.20	19.08	49.14	77.23	25.04
PEG Ratio	17.81	0.92	1.96	1.64	2.32	4.87
EV/Sales Ratio	4.64	3.65	6.92	11.66	18.27	14.24
EV/EBITDA Ratio	11.98	10.62	20.63	25.79	48.86	22.00
EV/EBIT Ratio	12.58	11.09	21.43	26.98	52.07	22.81
EV/FCF Ratio	13.43	10.35	16.26	47.03	77.81	23.50
Debt / Equity Ratio	0.03	0.03	0.02	0.02	0.02	0.02
Debt / EBITDA Ratio	0.10	0.14	0.14	0.09	0.14	0.05
Debt / FCF Ratio	0.11	0.14	0.11	0.17	0.22	0.05
Asset Turnover	0.58	0.53	0.50	0.53	0.37	0.56
Inventory Turnover	17.23	16.56	-	-	-	-
Quick Ratio	6.02	5.24	13.32	15.48	14.50	15.00
Current Ratio	6.03	5.25	13.34	15.48	14.50	15.00
Return on Equity (ROE)	29.41%	22.97%	14.78%	22.04%	14.31%	28.69%
Return on Assets (ROA)	13.38%	10.91%	10.17%	14.31%	8.06%	21.75%
Return on Capital (ROIC)	16.02%	12.62%	11.04%	15.51%	8.78%	23.44%
Return on Capital Employed (ROCE)	22.60%	17.50%	16.20%	22.10%	12.80%	31.70%
Earnings Yield	7.50%	8.27%	3.09%	2.84%	1.72%	2.95%
FCF Yield	6.29%	8.00%	4.98%	1.87%	1.15%	3.80%
Buyback Yield / Dilution	3.12%	1.94%	0.14%	0.06%	-0.24%	-3.53%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.